Artiva Biotherapeutics, Inc. ARTV Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s operating lease liabilities (current)?
- Artiva Biotherapeutics, Inc. (ARTV) reported operating lease liabilities (current) of $3.02M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s operating lease liabilities (current) changed year-over-year?
- Artiva Biotherapeutics, Inc.'s operating lease liabilities (current) decreased by 15.9% year-over-year, from $3.59M to $3.02M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s operating lease liabilities (current)?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s operating lease liabilities (current) has grown at a -8.4% compound annual growth rate (CAGR), from $3.6M to $3.02M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.